Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aebli N, Stich H, Schawalder P, Theis JC, Krebs J (2005) Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: an experimental study in sheep. J Biomed Mater Res A 73:295–302.
Auernheimer J, Zukowski D, Dahmen C, Kantlehner M, Enderle A, Goodman SL, Kessler H (2005) Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD-peptides. Chembiochem 6:2034–2040.
Bernhardt R, van den Dolder J, Bierbaum S, Beutner R, Scharnweber D, Jansen J, Beckmann F, Worch H (2005) Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR muCT and histology. Biomaterials 26:3009–3019.
Bosetti M, Verne E, Brovarone CV, Moisescu C, Sabbatini M, Cannas M (2003) Fluoroapatite glass-ceramic coating on alumina: surface behavior with biological fluids. J Biomed Mater Res A 66:615–621.
Boss JH, Shajrawi I, Mendes DG (1994) The nature of the bone-implant interface. The lessons learned from implant retrieval and analysis in man and experimental animal. Med Prog Technol 20:119–142.
Charnley J (1960) Anchorage of the femoral head prosthesis to the shaft of the femur. J Bone Joint Surg Br 42-B:28–30.:28–30.
Coventry MB (1975) Treatment of infections occurring in total hip surgery. Orthop Clin North Am 6:991–1003.
Dunn MG, Maxian SH (1991) Hydroxyapatite-coated orthopedic implants. J Long Term Eff Med Implants 1:193–203.
Effenberger H (1996) Zementfreie Standard-Schaftimplantate. In: Jerosch J, Effenberger, H, Fuchs, S (eds) Hüftendoprothetik: Biomaterialien, Design, Spätinfektion, Qualitätssicherung und Dokumentation. Thieme, Stuttgart, New York, pp 32–36.
Elmengaard B, Bechtold JE, Soballe K (2005) In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 26:3521–3526.
Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI (2003) Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74:644–651.
Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N (1997) Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 79:590–595.
Ferraris M, Verne E, Appendino P, Moisescu C, Krajewski A, Ravaglioli A, Piancastelli A (2000) Coatings on zirconia for medical applications. Biomaterials 21:765–773.
Geesink RG (2002) Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res 395:53–65.
Griss P, Greenspan DC, Heimke G, Krempien B, Buchinger R, Hench LL, Jentschura G (1976) Evaluation of a bioglass-coated Al2O3 total hip prosthesis in sheep. J Biomed Mater Res 10:511–518.
Gristina AG (1987) Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237:1588–1595.
Gristina AG, Hobgood CD, Webb LX, Myrvik QN (1987) Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials 8:423–426.
Hamadouche M, Meunier A, Greenspan DC, Blanchat C, Zhong JP, La Torre GP, Sedel L (2000) Bioactivity of sol-gel bioactive glass coated alumina implants. J Biomed Mater Res 52:422–429.
Harwood PJ, Giannoudis P, Giannoudis PV, Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S (2005) Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. Expert Opin Drug Saf 4:75–89.
Hench LL, Pantano CG, Jr., Buscemi PJ, Greenspan DC (1977) Analysis of bioglass fixation of hip prostheses. J Biomed Mater Res 11:267–282.
Heness G, Ben-Nissan B (2004) Innovative bioceramics. Materials Forum 27:104–114.
Hoffmann J, Cornelius CP, Groten M, Probster L, Pfannenberg C, Schwenzer N (1998) Orbital reconstruction with individually copy-milled ceramic implants. Plast Reconstr Surg 101:604–612.
Holzer B, Grussner U, Bruckner B, Houf M, Kiffner E, Schildberg FW, Vogel P, Rosen HR (2003) Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll) after surgical treatment of a pilonidal sinus. Colorectal Dis 5:222–227.
Horton MA, Townsend P and Nesbitt S (1996) Cell surface attachment molecules in bone. In: Bilezikian JP, Raisz LG and Rodan GA (eds) Principles of bone biology. Academic Press, San Diego, London, pp 217–230.
Ignatius A, Peraus M, Schorlemmer S, Augat P, Burger W, Leyen S, Claes L (2005) Osseointegration of alumina with a bioactive coating under load-bearing and unloaded conditions. Biomaterials 26:2325–2332.
Jenissen HP, Zumbrink T, Chatzinikolaidou M, Steppuhn J (1999) Biocoating of implants with mediator molecules: surface enhancement of metals by treatment with chromosulfuric acid. Materialwissenschaften und Werkstofftechnik 30:838–845.
Johnston DW, Davies DM, Beaupre LA, Lavoie G (2001) Standard anatomical medullary locking (AML) versus tricalcium phosphate-coated AML femoral prostheses. Can J Surg 44:421–427.
Kakutani Y, Yamamuro T, Nakamura T, Kotoura Y (1989) Strengthening of bone-implant interface by the use of granule coatings on alumina ceramics. J Biomed Mater Res 23:781–808.
Kim HW, Georgiou G, Knowles JC, Koh YH, Kim HE (2004) Calcium phosphates and glass composite coatings on zirconia for enhanced biocompatibility. Biomaterials 25:4203–4213.
Kitsugi T, Nakamura T, Oka M, Senaha Y, Goto T, Shibuya T (1996) Bone-bonding behavior of plasma-sprayed coatings of BioglassR, AW-glass ceramic, and tricalcium phosphate on titanium alloy. J Biomed Mater Res 30:261–269.
Kokubo T, Kim HM, Kawashita M, Nakamura T (2001) Process of calcification on artificial materials. Z Kardiol 90Suppl 3:86–91.:86–91.
Kokubo T, Kushitani H, Ebisawa Y, Kitsugi T, Kotani S, Ohura K and Yamamuro T (1989) Apatite formation on bioactive ceramics in body environment. In: Oonishi H, Aoki H and Sawai K (eds) Bioceramics. Ishiyaku Euro America, Tokyo, pp 157–162.
Kong YM, Bae CJ, Lee SH, Kim HW, Kim HE (2005) Improvement in biocompatibility of ZrO2-Al2O3 nano-composite by addition of HA. Biomaterials 26:509–517.
Krajewski A, Ravaglioli A, Mazzocchi M, Fini M (1998) Coating of ZrO2 supports with a biological glass. J Mater Sci Mater Med 9:309–316.
Landegren U (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67:379–388.
Li P, Ohtsuki C, Kokubo T, Nakanishi K, Soga N, de Groot K (1994) The role of hydrated silica, titania, and alumina in inducing apatite on implants. J Biomed Mater Res 28:7–15.
Lichtinger TK, Müller RT, Schürmann N, Oldenburg M, Wiemann M, Chatzinikolaidou M, Rumpf HM, Jenissen HP (2001) Osseointegration of titanium implants by addition of recombinant bone morphogenetic protein 2 (rhBMP-2). Materialwissenschaften und Werkstofftechnik 32:941.
Lind M, Overgaard S, Bunger C, Soballe K (1999) Improved bone anchorage of hydroxypatite coated implants compared with tricalcium-phosphate coated implants in trabecular bone in dogs. Biomaterials 20:803–808.
Liu Y, de Groot K, Hunziker EB (2005) BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 36:745–757.
Lopez-Sastre S, Gonzalo-Orden JM, Altonaga JA, Altonaga JR, Orden MA (1998) Coating titanium implants with bioglass and with hydroxyapatite. A comparative study in sheep. Int Orthop 22:380–383.
Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, Raschke M (2003) Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32:521–531.
Lucke M, Wildemann B, Sadoni S, Surke C, Schiller R, Stemberger A, Raschke M, Haas NP, Schmidmaier G (2005) Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 36:770–778.
Malchau H, Herberts P, Eisler T, Garellick G, Soderman P (2002) The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 84-ASuppl 2:2–20.:2–20.
Mallory TH, Lombardi AV, Jr., Leith JR, Fujita H, Hartman JF, Capps SG, Kefauver CA, Adams JB, Vorys GC (2002) Why a taper? J Bone Joint Surg Am 84-ASuppl 2:81–9.:81–89.
Mjöberg B (1991) Fixation and loosening of hip prostheses. A review. Acta Orthop Scand 62:500–508.
Pizzoferrato A, Toni A, Sudanese A, Ciapetti G, Tinti A, Venturini A (1988) Multilayered bead ceramic composite coating for hip prostheses: experimental studies and preliminary clinical results. J Biomed Mater Res 22:1181–1202.
Radin S, Campbell JT, Ducheyne P, Cuckler JM (1997) Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 18:777–782.
Ripamonti U, Ramoshebi LN, Matsaba T, Tasker J, Crooks J, Teare J (2001) Bone induction by BMPs/OPs and related family members in primates. J Bone Joint Surg Am 83-ASuppl 1:S116–S127.
Rokkum M, Reigstad A, Johansson CB (2002) HA particles can be released from wellfixed HA-coated stems: histopathology of biopsies from 20 hips 2-8 years after implantation. Acta Orthop Scand 73:298–306.
Rossler S, Sewing A, Stolzel M, Born R, Scharnweber D, Dard M, Worch H (2003) Electrochemically assisted deposition of thin calcium phosphate coatings at nearphysiological pH and temperature. J Biomed Mater Res A 64:655–663.
Saiz E, Goldman M, Gomez-Vega JM, Tomsia AP, Marshall GW, Marshall SJ (2002) In vitro behavior of silicate glass coatings on Ti6A14V. Biomaterials 23:3749–3756.
Schaffner P, Dard MM (2003) Structure and function of RGD peptides involved in bone biology. Cell Mol Life Sci 60:119–132.
Schaffner P, Meyer J, Dard M, Nies B, Verrier S, Kessler H, Kantlehner M (1999) Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies. J Mater Sci Mater Med 10:837–839.
Schliephake H, Scharnweber D, Dard M, Robetaler S, Sewing A, Huttmann C (2003) Biological performance of biomimetic calcium phosphate coating of titanium implants in the dog mandible. J Biomed Mater Res A 64:225–234.
Schmidmaier G, Wildemann B, Schwabe P, Stange R, Hoffmann J, Sudkamp NP, Haas NP, Raschke M (2002) A new electrochemically graded hydroxyapatite coating for osteosynthetic implants promotes implant osteointegration in a rat model. J Biomed Mater Res 63:168–172.
Shepperd JA, Apthorp H (2005) A contemporary snapshot of the use of hydroxyapatite coating in orthopaedic surgery. J Bone Joint Surg Br 87:1046–1049.
Soballe K, Hansen ES, Brockstedt-Rasmussen H, Bunger C (1993) Hydroxyapatite coating converts fibrous tissue to bone around loaded implants. J Bone Joint Surg Br 75:270–278.
Steinhauser E, Liebendörfer A, Enderle A, Bader R, Kerschbaumer S, Brill T, Busch R, Gradinger R (2005) In-vivo-Studie zur knöchernen Integration von RGD-Peptid-beschichteten und unbeschichteten metallischen Implantaten. MP Materialprufung 47:197–202.
Stigter M, Bezemer J, de Groot K, Layrolle P (2004) Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 99:127–137.
Stigter M, de Groot K, Layrolle P (2002) Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 23:4143–4153.
Thomas MV, Puleo DA, Al Sabbagh M (2005) Bioactive glass three decades on. J Long Term Eff Med Implants 15:585–597.
Trikha SP, Singh S, Raynham OW, Lewis JC, Mitchell PA, Edge AJ (2005) Hydroxyapatiteceramic-coated femoral stems in revision hip surgery. J Bone Joint Surg Br 87:1055–1060
Vogely HC, Oosterbos CJ, Puts EW, Nijhof MW, Nikkels PG, Fleer A, Tonino AJ, Dhert WJ, Verbout AJ (2000) Effects of hydroxyapatite coating on Ti-6A1-4V implant-site infection in a rabbit tibial model. J Orthop Res 18:485–493.
Wahlig H, Dingeldein E (1980) Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 51:49–56.
Wen HB, de Wijn JR, van Blitterswijk CA, de Groot K (1999) Incorporation of bovine serum albumin in calcium phosphate coating on titanium. J Biomed Mater Res 46:245–252.
Wildemann B, Kandziora F, Krummrey G, Palasdies N, Haas NP, Raschke M, Schmidmaier G (2004) Local and controlled release of growth factors (combination of IGF-I and TGFbeta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle. J Control Release 95:249–256.
Windler M and Klabunde R (2001) Titanium for hip and knee prostheses. In: Brunette DM, Tengvall P, Textor M and Thomsen P (eds) Titanium in medicine: material science, surface science, engineering, biological responses and medical applications. Springer, Berlin, Heidelberg, pp 703–746.
Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191–1200.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Steinkopff Verlag, Darmstadt
About this paper
Cite this paper
Mannel, H., Zukowski, D., Sewing, A., Alt, V. (2006). Surface Activation of Implants. In: Benazzo, F., Falez, F., Dietrich, M. (eds) Bioceramics and Alternative Bearings in Joint Arthroplasty. Ceramics in Orthopaedics. Steinkopff. https://doi.org/10.1007/978-3-7985-1635-9_41
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1635-9_41
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1634-2
Online ISBN: 978-3-7985-1635-9
eBook Packages: MedicineMedicine (R0)